Cargando…
Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the most common malignant tumours worldwide. Therefore, the identification and development of sensitivity- genes as novel diagnostic markers and effective therapeutic targets is urgently needed. Dopamine and dopamine receptor D1 (DRD1) are re...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557590/ https://www.ncbi.nlm.nih.gov/pubmed/34717619 http://dx.doi.org/10.1186/s12935-021-02298-9 |